Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer.
Yoann PointreauRené-Jean BensadounGuillaume BeraChristian SireAmandine RuffierGuillaume JanorayGilles CalaisMarc BolletBaptiste PinelViorica BranisteXavier AmoresPublished in: Patient preference and adherence (2020)
This study showed, in a real-life setting, that a clear majority of H&N cancer patients treated with FPNS for BTcP throughout radiotherapy expressed satisfaction with this analgesic treatment.